Lv1
38 积分 2021-06-29 加入
Combination of ligand‑based and structure‑based virtual screening for the discovery of novel Janus kinase 2 inhibitors against philadelphia-negative myeloproliferative neoplasms
2个月前
已完结
Advances in Machine Learning Models for Healthcare Applications: A Precise and Patient-Centric Approach
4个月前
已完结
GPCR drug discovery: new agents, targets and indications
4个月前
已完结
Repurposing of SARS-CoV-2 compounds against Marburg Virus using MD simulation, mm/GBSA, PCA analysis, and free energy landscape
8个月前
已完结
A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
9个月前
已完结
Biogenic silver nanoparticle synthesis and stabilization for apoptotic activity; insights from experimental and theoretical studies
10个月前
已完结
An In-Silico Drug Designing Approach Attempted on a Newly Synthesized Co(II) Complex along with its Other Biological Activities: A Combined Investigation of both Experimental and Theoretical Aspects
10个月前
已完结
NaV1.8 inhibitor poised to provide opioid-free pain relief
11个月前
已关闭
Abstract 4441: CS3003, an HDAC6-selective inhibitor, improves anti-PD-1 immune checkpoint blockade therapy efficacy
11个月前
已关闭
Discovery of Novel Imidazo[1,2-a]pyridine-Based HDAC6 Inhibitors as an Anticarcinogen with a Cardioprotective Effect
1年前
已完结
Open-label randomized multi-center phase 2 study: gemcitabine cisplatin plus avelumab or gemcitabine cisplatin as first-line treatment of patients with locally advanced or metastatic urothelial bladder carcinoma: GCisAve
皖公网安备34019202002308
